Centre for Biomedical Network Research on Rare Diseases
In research, Centre for Biomedical Network Research on Rare Diseases stands highest in Health Sciences (#984 of 9,902 worldwide), Medicine (#858 of 8,541 worldwide) and Life Sciences (#1,370 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Genetics (Genetics is 7.8× its share of world research).
- World rank, 2022-now
- #4,207 of 22,385 · #2,321 all time
- Rank in Spain
- #97 of 426
- Research works
- 1.9k ◆ 1% vs 2018-21
- Citations
- 55k 28.8 per fractional work
- Top-10% rate
- 14.6% all institutions 10.0%
- vs its own fields
- 1.17× 1.00× is exactly expected
- Open access
- 63% world 40%
- International
- 38% world 18%
What is Centre for Biomedical Network Research on Rare Diseases known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #984 of 9,902 | 16.8% | 270 | #798 | |
| MedicineField | #858 of 8,541 | 16.9% | 259 | #713 | |
| Life SciencesDomain | #1,370 of 6,403 | 11.2% | 198 | #1133 | |
| Biochemistry, Genetics and Molecular BiologyField | #978 of 2,964 | 9.7% | 143 | #880 | |
| Molecular BiologySubfield | #912 of 1,880 | 8.8% | 80 | #900 |
Each strip is that field's whole ranked pool, with the notch where Centre for Biomedical Network Research on Rare Diseases sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#798 #984
- Medicine#713 #858
- Life Sciences#1,133 #1,370
- Biochemistry, Genetics and Molecular Biology#880 #978
- Molecular Biology#900 #912
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Centre for Biomedical Network Research on Rare Diseases work in?
In 2022-now, 54% of research at Centre for Biomedical Network Research on Rare Diseases is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (5%). It does 2.9× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences29854.0%
- Medicine28651.8%
- Health Professions71.3%
- Nursing30.6%
- Dentistry10.2%
- Veterinary10.2%
- Life Sciences21839.5%
- Physical Sciences203.5%
- Engineering40.8%
- Environmental Science40.7%
- Chemistry40.6%
- Materials Science20.4%
- Computer Science20.4%
- Mathematics20.3%
- Physics and Astronomy10.1%
- Energy10.1%
- Chemical Engineering00.0%
- Earth and Planetary Sciences00.0%
- Social Sciences173.0%
What does Centre for Biomedical Network Research on Rare Diseases specialise in?
Where its research is concentrated relative to its size: Genetics takes 7.8× the share of its output that it takes of world research.
- GeneticsSubfield · 35.7 works7.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.3×. Every wedge is a field page.
All 26 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology5.30×156 works
- Immunology and Microbiology4.53×25 works
- Neuroscience3.20×29 works
- Medicine2.69×286 works
- Veterinary1.24×1 works
- Pharmacology, Toxicology and Pharmaceutics1.22×2 works
- Nursing1.20×3 works
- Psychology0.53×9 works
- Health Professions0.48×7 works
- Chemistry0.41×4 works
- Dentistry0.36×1 works
- Mathematics0.24×2 works
- Agricultural and Biological Sciences0.21×6 works
- Environmental Science0.14×4 works
- Materials Science0.13×2 works
- Chemical Engineering0.11×0 works
- Decision Sciences0.11×1 works
- Economics, Econometrics and Finance0.11×1 works
- Energy0.10×0 works
- Arts and Humanities0.08×1 works
- Social Sciences0.06×4 works
- Computer Science0.05×2 works
- Engineering0.05×4 works
- Physics and Astronomy0.05×1 works
- Earth and Planetary Sciences0.02×0 works
- Business, Management and Accounting0.02×0 works
- Biochemistry, Genetics and Molecular Biology 5.3×
- Immunology and Microbiology 4.5×
- Neuroscience 3.2×
- Medicine 2.7×
- Veterinary 1.2×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Nursing 1.2×
- Psychology 0.5×
- Health Professions 0.5×
- Chemistry 0.4×
- Dentistry 0.4×
- Mathematics 0.2×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.1×
- Materials Science 0.1×
- Chemical Engineering 0.1×
- Decision Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Energy 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Centre for Biomedical Network Research on Rare Diseases?
Ranked on the quality score, Cristina Ugalde, Jonathan D. Schwartz and Maria Lourdes Arbonés lead among researchers whose main affiliation is Centre for Biomedical Network Research on Rare Diseases.
- 1
Cristina Ugalde
Spain · #246,629 worldwide 4.1k citations · 77 works
- 2
Jonathan D. Schwartz
Spain · #278,926 worldwide 9.3k citations · 106 works
- 3
Maria Lourdes Arbonés
Spain · #418,014 worldwide 6.4k citations · 84 works
- 4
Miguel López de Heredia
Spain · #468,703 worldwide 2.7k citations · 66 works
- 5
Alberto García‐Redondo
Spain · #502,753 worldwide 4.5k citations · 79 works
- 6
Ivon Cuscó
Spain · #558,176 worldwide 3k citations · 78 works
- 7
Begoña Díez
Spain · #635,892 worldwide 1.7k citations · 37 works
- 8
Benjamín Rodríguez‐Santiago
Spain · #645,831 worldwide 3.2k citations · 76 works
- 9
José María Millán
Spain · #728,175 worldwide 7.3k citations · 218 works
- 10
Gema García‐García
Spain · #780,502 worldwide 1.8k citations · 67 works
Which keywords describe research at Centre for Biomedical Network Research on Rare Diseases?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Inflammation, Genetic Mutations, Oxidative Stress, Mitochondrial Dysfunction, Cancer, Cell Death and Treatment.
- Dendritic Spines
- Hearing Loss
- ACE2 Receptor
- Mitochondrial Fusion
- Thrombosis
- Stem Cells
- Innate Immunity
- SARS-CoV-2
- Gene Expression
- Neurodegenerative Diseases
- Mitochondria
- Genetic Variants
- Cell Death
- Immunotherapy
- Aging
- Metabolic Syndrome
- Cardiovascular Disease
- Mitochondrial Dysfunction
- Cancer
- Inflammation
- Epidemiology
- Oxidative Stress
- Genetic Mutations
- Treatment
- Diagnosis
- Neurological Disorders
- Genetics
- Immune Response
- Reactive Oxygen Species
- Metabolism
- Neurodegeneration
- Metabolic Regulation
- Immunity
- Clinical Genomics
- Sequence Interpretation
- Endothelial Dysfunction
- Mitochondrial Fission
- Autoantibodies
- Clinical Management
- Brain Development
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology55▲ 2.5×116 topics
- Inflammation43▲ 3.6×78 topics
- Oxidative Stress36▲ 3.9×53 topics
- Cancer28▲ 3.7×48 topics
- Genetic Mutations26▲ 11×22 topics
- Mitochondrial Dysfunction23▲ 14×11 topics
- Treatment20▲ 3.0×43 topics
- Cardiovascular Disease18▲ 2.8×35 topics
- Diagnosis18▲ 3.4×36 topics
- Metabolic Syndrome16▲ 3.5×21 topics
- Neurological Disorders15▲ 4.8×19 topics
- Aging15▲ 5.0×16 topics
- Genetics15▲ 3.8×19 topics
- Immunotherapy14▲ 3.5×18 topics
- Immune Response13▲ 4.2×20 topics
- Cell Death13▲ 9.9×6 topics
- Reactive Oxygen Species13▲ 5.7×13 topics
- Genetic Variants12▲ 12×7 topics
- Metabolism12▲ 4.1×23 topics
- Mitochondria12▲ 15×6 topics
- Neurodegeneration11▲ 6.5×10 topics
- Neurodegenerative Diseases11▲ 12×7 topics
- Metabolic Regulation11▲ 12×4 topics
- Gene Expression11▲ 3.1×18 topics
- Immunity11▲ 4.8×9 topics
- SARS-CoV-211▲ 6.3×6 topics
- Clinical Genomics9▲ 43×1 topic
- Innate Immunity9▲ 5.2×11 topics
- Sequence Interpretation9▲ 43×1 topic
- Stem Cells9▲ 6.2×15 topics
- Endothelial Dysfunction9▲ 7.0×8 topics
- Thrombosis9▲ 5.9×7 topics
- Mitochondrial Fission9▲ 31×1 topic
- Mitochondrial Fusion9▲ 31×1 topic
- Autoantibodies9▲ 6.7×8 topics
- ACE2 Receptor8▲ 6.7×3 topics
- Clinical Management8▲ 8.3×8 topics
- Hearing Loss8▲ 12×4 topics
- Brain Development7▲ 7.6×6 topics
- Dendritic Spines7▲ 16×2 topics
Which research topics does Centre for Biomedical Network Research on Rare Diseases publish most on?
By volume in 2022-now: Genomics and Rare Diseases, Mitochondrial Function and Pathology, Genetic Neurodegenerative Diseases and Genetics and Neurodevelopmental Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genomics and Rare Diseases Genetics 9 works
- 2 Mitochondrial Function and Pathology Molecular Biology 9 works
- 3 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 5 works
- 4 Genetics and Neurodevelopmental Disorders Genetics 5 works
- 5 Metabolism and Genetic Disorders Clinical Biochemistry 5 works
- 6 COVID-19 Clinical Research Studies Infectious Diseases 4 works
- 7 Neurogenetic and Muscular Disorders Research Genetics 4 works
- 8 Muscle Physiology and Disorders Molecular Biology 4 works
- 9 Pregnancy and preeclampsia studies Obstetrics and Gynecology 4 works
- 10 Epigenetics and DNA Methylation Molecular Biology 4 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Centre for Biomedical Network Research on Rare Diseases's research output changed?
Output in 2022-2025 was 1% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Centre for Biomedical Network Research on Rare Diseases as a percentage of every work published that year, 0.0023% in 2024.
Fractional works of Centre for Biomedical Network Research on Rare Diseases over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.0% in 2015.
Other research institutions in Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Instituto de Salud Carlos III
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Centre for Biomedical Network Research on Rare Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
